VEGFA and neoplasm: The expanding role of anti-VEGF treatment for metastatic colorectal tumour patients, along with the growing number of cases potentially requiring such a treatment approach, made the need for a reliable identification of responding tumours increasingly crucial (Folkman, 1971).